Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI


Primary Symbol: V.BTI.H Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by jdstoxon Mar 23, 2018 1:59pm
332 Views
Post# 27771553

Silly Selling

Silly Selling
Once again we get a little upward pressure, obviously too much of a good thing for some people, and what happens? Instead of letting their offers get taken out, some folks just have to sell into the bids. 
 
Time and again we've seen this, buyers who are prepared to chase it higher, only to be taught that the new price they were willing to pay will be undercut by people who are either malicious in their selling or just don't understand the concept of a rising market and the increased profits it can bring.
 
If this is caused by traders who are helping to cause and then break the momentum for their own interests then, just once, I would love to see buyers break the cycle by buying it higher and forcing traders, who sold in an effort to hold it down, would themselves have to buy at higher prices and contribute to some momentum for a change.

The recent buying is mostly from the USA where our story may finally be getting some traction, even without news. As stated in the MD&A, Bioasis is moving ahead on many fronts. These efforts are being expended in the pursuit of specific objectives, some publicly discussed, some not so much. When serious, highly capable people pursue serious objectives, serious results should not surprise anybody. Expect results from these efforts.

jdstox
 
Bullboard Posts